Therapy of gallstone disease: What it was, what it is, what it will be
- 1 January 2012
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Pharmacology and Therapeutics
- Vol. 3 (2), 7-20
- https://doi.org/10.4292/wjgpt.v3.i2.7
Abstract
Cholesterol gallstone disease is a common clinical condition influenced by genetic factors, increasing age, female gender, and metabolic factors. Although laparoscopic cholecystectomy is currently considered the gold standard in treating patients with symptomatic gallstones, new perspectives regarding medical therapy of cholelithiasis are currently under discussion, also taking into account the pathogenesis of gallstones, the natural history of the disease and the analysis of the overall costs of therapy. A careful selection of patients may lead to successful non-surgical therapy in symptomatic subjects with a functioning gallbladder harboring small radiolucent stones. The classical oral litholysis by ursodeoxycholic acid has been recently paralleled by new experimental observations, suggesting that cholesterol-lowering agents which inhibit cholesterol synthesis (statins) or intestinal cholesterol absorption (ezetimibe), or drugs acting on specific nuclear receptors involved in cholesterol and bile acid homeostasis, might be proposed as additional approaches for treating cholesterol gallstones. In this review we discuss old, recent and future perspectives on medical treatment of cholesterol cholelithiasisKeywords
This publication has 99 references indexed in Scilit:
- Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatmentsJournal of Hepatology, 1998
- Meperidine need not be proscribed during sphincter of Oddi manometryGastrointestinal Endoscopy, 1994
- Gallbladder emptying is an important factor in fragment disappearance after shock wave lithotripsyJournal of Hepatology, 1993
- Asymptomatic gallstonesBritish Journal of Surgery, 1990
- Dissolution of Cholesterol Gallbladder Stones by MethylTert-Butyl Ether Administered by Percutaneous Transhepatic CatheterThe New England Journal of Medicine, 1989
- Gallstone Growth, Size, and Risk of Gallbladder Cancer: An Interracial StudyInternational Journal of Epidemiology, 1989
- Fragmentation of Gallstones by Extracorporeal Shock WavesThe New England Journal of Medicine, 1986
- Gallstone dissolution rate during chenic acid therapyDigestive Diseases and Sciences, 1982
- The Natural History of Silent GallstonesThe New England Journal of Medicine, 1982
- Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid.BMJ, 1981